P-291 - NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option.
Saved in:
| Title: | P-291 - NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option. |
|---|---|
| Authors: | Weinberg, B.1 (AUTHOR), Renouf, D.2 (AUTHOR), Lim, H.2 (AUTHOR), Heining, C.3 (AUTHOR), Schlenk, R.4 (AUTHOR), Jones, M.5 (AUTHOR), Liu, S.1 (AUTHOR), Cseh, A.6 (AUTHOR), Solca, F.6 (AUTHOR), Laskin, J.2 (AUTHOR) |
| Source: | Annals of Oncology. 2019 Supplement, Vol. 30, piv80-iv80. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152694391 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: P-291 - NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Weinberg%2C+B%2E%22">Weinberg, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Renouf%2C+D%2E%22">Renouf, D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lim%2C+H%2E%22">Lim, H.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Heining%2C+C%2E%22">Heining, C.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schlenk%2C+R%2E%22">Schlenk, R.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jones%2C+M%2E%22">Jones, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+S%2E%22">Liu, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cseh%2C+A%2E%22">Cseh, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Solca%2C+F%2E%22">Solca, F.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Laskin%2C+J%2E%22">Laskin, J.</searchLink><relatesTo>2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2019 Supplement, Vol. 30, piv80-iv80. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152694391 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdz155.290 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: iv80 Titles: – TitleFull: P-291 - NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Weinberg, B. – PersonEntity: Name: NameFull: Renouf, D. – PersonEntity: Name: NameFull: Lim, H. – PersonEntity: Name: NameFull: Heining, C. – PersonEntity: Name: NameFull: Schlenk, R. – PersonEntity: Name: NameFull: Jones, M. – PersonEntity: Name: NameFull: Liu, S. – PersonEntity: Name: NameFull: Cseh, A. – PersonEntity: Name: NameFull: Solca, F. – PersonEntity: Name: NameFull: Laskin, J. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 07 Text: 2019 Supplement Type: published Y: 2019 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 30 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |